TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 5nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 5.01nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 5.01nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 6.30nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 6.31nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 6.31nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 12.6nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 12.6nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 15.8nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 15.8nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 25nMAssay Description:Displacement of [125I]CCK-8S from CCK2 receptorMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 25nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 25nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 25.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 25.1nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 31.6nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 32nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 39.8nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 40nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 40nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 50nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 50.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 63nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 63nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 63nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 63.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 63.1nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 79nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 79nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 79nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 79nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 79nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 79.4nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Displacement of [125I]-CCK-8S from CCK1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 100nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 126nMAssay Description:Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation countingMore data for this Ligand-Target Pair
TargetOrexin receptor type 2(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 126nMAssay Description:Binding affinity towards human orexin receptor type 2 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson and Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 126nMAssay Description:Binding affinity towards human orexin receptor type 1 was determined using [125I]-Orexin A as radio ligandMore data for this Ligand-Target Pair